sepsis - Nursing Case Study

Pathophysiology

• Primary mechanism: In sepsis, a systemic inflammatory response is triggered by an infection, leading to the widespread release of pro-inflammatory cytokines. This cytokine storm causes endothelial dysfunction and increased vascular permeability, contributing to hypotension and tissue hypoperfusion.

• Secondary mechanism: The inflammatory response activates the coagulation cascade excessively, resulting in disseminated intravascular coagulation (DIC). This leads to microvascular thrombosis, further impairing blood flow and oxygen delivery to tissues, exacerbating organ dysfunction.

• Key complication: The combination of impaired blood flow, hypoperfusion, and coagulation abnormalities can lead to multi-organ failure, significantly increasing morbidity and mortality in septic patients.

Patient Profile

Demographics:

56-year-old female, retired school teacher

History:

• Key past medical history: Type 2 Diabetes, Hypertension

• Current medications: Metformin, Lisinopril, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Fever and confusion

• Key symptoms: Shortness of breath, decreased urine output, chills, and fatigue

• Vital signs: Temperature 38.9°C (102°F), Heart rate 110 bpm, Respiratory rate 24 breaths per minute, Blood pressure 90/60 mmHg, Oxygen saturation 92% on room air

Section 1

As the medical team continues to monitor the patient, new diagnostic results paint a clearer, yet more concerning picture of her condition. Blood cultures reveal the presence of Escherichia coli, confirming a urinary tract infection as the source of sepsis. Additionally, laboratory tests indicate elevated white blood cell count, significant lactic acidosis with a lactate level of 4.5 mmol/L, and increased creatinine levels at 2.1 mg/dL, suggesting acute kidney injury. The coagulation profile shows prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), alongside decreased platelet count, raising suspicion for disseminated intravascular coagulation (DIC).

These findings necessitate immediate clinical reasoning and adaptation of the treatment plan. Given the confirmed bacterial source and the patient's allergy to penicillin, the medical team decides to initiate a broad-spectrum antibiotic regimen using a combination of meropenem and levofloxacin. Concurrently, fluid resuscitation is intensified with isotonic crystalloids to counteract hypotension and improve tissue perfusion. Close monitoring of the patient's renal function and coagulation parameters becomes crucial, as the risk of multi-organ failure looms.

The patient's response to these interventions will be critical in determining the next steps. The team must remain vigilant for signs of deteriorating organ function or new complications, such as acute respiratory distress syndrome (ARDS) or worsening renal failure, which would require further adjustments in management strategies. Continuous assessment of vital signs, urine output, and laboratory values will guide the ongoing treatment, with the goal of stabilizing the patient's condition and preventing further progression of sepsis-related complications.

Section 2

The patient's condition remains tenuous as the medical team continues to closely monitor her response to the interventions. Despite aggressive fluid resuscitation, her blood pressure remains borderline, fluctuating between 90/60 mmHg and 95/65 mmHg. Her heart rate is persistently elevated at 120 beats per minute, indicating ongoing compensatory tachycardia. Urine output is minimal at 15 mL/hr, further reinforcing the concern for worsening renal function. The team notes that her respiratory rate has increased to 28 breaths per minute, with shallow breathing patterns and an oxygen saturation hovering around 92% on supplemental oxygen via nasal cannula at 3 L/min.

New laboratory results show a further rise in serum creatinine to 2.6 mg/dL, confirming the progression of acute kidney injury. Additionally, the lactate level has decreased only marginally to 4.0 mmol/L, suggesting that tissue perfusion remains inadequate. Her coagulation profile continues to worsen, with PT now at 19 seconds and aPTT at 55 seconds, while platelets have dropped to 85,000/mm³, indicating that DIC is not yet under control. These findings prompt the medical team to consider the need for additional supportive measures such as renal replacement therapy and more aggressive management of coagulopathy.

Given the emerging signs of acute respiratory distress syndrome (ARDS), characterized by her increased respiratory effort and hypoxemia, the team contemplates the necessity of transitioning to non-invasive positive pressure ventilation to improve oxygenation and reduce respiratory workload. The patient's clinical picture highlights the delicate balance between supporting organ function and preventing further deterioration. The multidisciplinary team must carefully weigh the risks and benefits of each intervention, with a focus on optimizing fluid management, adjusting antimicrobial therapy as needed, and potentially introducing mechanical support to stabilize the patient's condition.

Section 3

As the medical team intensifies their focus on the patient's respiratory status, they decide to initiate non-invasive positive pressure ventilation to address the emerging signs of acute respiratory distress syndrome (ARDS). The transition to BiPAP at 10/5 cm H2O with a FiO2 of 60% results in a slight improvement in her oxygen saturation, which now averages 94%. Her respiratory rate decreases to 24 breaths per minute, and her breathing pattern becomes slightly less labored, indicating a modest reduction in respiratory workload. Despite these improvements, the patient remains tachycardic with a heart rate of 115 beats per minute, reflecting ongoing systemic stress.

In parallel, the nephrology team is consulted regarding the patient's worsening renal function. Given the persistently low urine output and rising creatinine levels, the decision is made to initiate continuous renal replacement therapy (CRRT) to support her compromised kidney function and facilitate fluid balance. This intervention is expected to help alleviate fluid overload, which may further improve her respiratory status by reducing pulmonary congestion. As CRRT begins, the team closely monitors the patient for any signs of hemodynamic instability, given her borderline blood pressure.

Meanwhile, the hematology team addresses the ongoing coagulopathy. Fresh frozen plasma and platelet transfusions are administered to correct the patient's prolonged PT and low platelet count, aiming to stabilize her coagulation parameters and mitigate the risk of bleeding. Regular reassessment of her coagulation status is necessary to guide further treatment. As these interventions unfold, the medical team remains vigilant for any new complications, recognizing that the patient's condition remains highly dynamic and requires constant reevaluation and adjustment of the treatment plan.

Section 4

As the medical team continues to monitor the patient's progress, a new set of diagnostic results reveals additional complications. Blood cultures have returned positive for gram-negative bacteria, prompting an immediate review of her antibiotic regimen. The infectious disease team recommends broadening antibiotic coverage to include a combination of piperacillin-tazobactam and levofloxacin, targeting both gram-negative and atypical pathogens. This adjustment aims to address the persistent infection and prevent further systemic deterioration.

Despite the intervention with CRRT, the patient's renal function remains compromised, with her creatinine level stabilizing but still elevated at 3.5 mg/dL. Her urine output remains minimal, and fluid balance is closely maintained to avoid exacerbating pulmonary congestion. The nephrology team continues to adjust the CRRT settings to optimize clearance and fluid removal, while the intensivists closely monitor her hemodynamic status. The patient's blood pressure hovers around 95/60 mmHg, necessitating cautious administration of vasopressors to maintain adequate perfusion without compromising her already stressed cardiovascular system.

As the respiratory status shows slight improvement with BiPAP support, the focus shifts to her cardiovascular stability. The ongoing tachycardia and borderline hypotension suggest persistent systemic stress, likely exacerbated by the sepsis and respiratory demands. The medical team considers the potential need for an echocardiogram to assess cardiac function, given the strain on her heart. The patient's fluid status, vasopressor requirements, and overall response to the adjusted antibiotic regimen will be crucial in determining the next steps. Close monitoring and frequent reassessment remain essential, as the team anticipates further complications that may necessitate rapid intervention.

Section 5

New Complications

As the treatment progresses, the medical team observes the development of new complications, highlighting the complexity of the patient's condition. The patient begins to exhibit signs of acute delirium, characterized by episodes of confusion, agitation, and disorientation. This change raises concerns about potential neurological complications, possibly linked to septic encephalopathy or the side effects of medications, including vasopressors and antibiotics. The neurology team is consulted to evaluate her mental status, considering potential metabolic imbalances or hypoperfusion as contributing factors. Continuous EEG monitoring is initiated to assess for any underlying seizure activity and to guide further management.

Simultaneously, new laboratory results indicate a drop in her platelet count to 75,000/µL, raising the concern of developing thrombocytopenia, a common complication in severe sepsis. The hematology team is involved to investigate possible causes, including disseminated intravascular coagulation (DIC), given her existing infection and systemic inflammatory response. With the patient's INR slightly elevated at 1.4 and fibrinogen levels borderline low, the team decides to initiate DIC scoring and consider supportive treatments like platelet transfusions if necessary. This thrombocytopenia adds another layer of complexity, necessitating careful monitoring for any signs of bleeding, especially given her altered mental status.

These evolving complications underscore the importance of an integrated approach, where the medical team must carefully balance the management of her sepsis, renal impairment, and now, potential neurological and hematological issues. The interdisciplinary team's regular meetings focus on adjusting the treatment plan, ensuring timely interventions, and closely monitoring her response. The patient's journey continues to be fraught with challenges, but the proactive and coordinated efforts aim to stabilize her condition and prevent further deterioration. As the team navigates these complexities, they remain vigilant for any new signs that could signal additional complications or indicate progress in her recovery.